• Users Online: 212
  • Print this page
  • Email this page


 
 Table of Contents  
ORIGINAL ARTICLE
Year : 2021  |  Volume : 8  |  Issue : 3  |  Page : 205-211

An investigation of hospital anxiety and depression and associated factors in COVID-19 patients


1 Critical Care Nursing, Traditional and Complementary Medicine Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran
2 Professor, Traditional and Complementary Medicine Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran; World Federation of Acupuncture-Moxibustion Societies (WFAS), Beijing, China
3 Information Science, Mazandaran University of Medical Sciences, Sari, Iran

Date of Submission21-Dec-2020
Date of Acceptance26-Apr-2021
Date of Web Publication19-Jul-2021

Correspondence Address:
Mrs. Seyed Robabeh Babaei
Master of Special Nursing, Nasibeh School of Nursing and Midwifery, Mazandaran University of Medical Sciences, Sari
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jnms.jnms_178_20

Rights and Permissions
  Abstract 


Context: The high incidence of anxiety and depression in patients with corona can be associated with serious complications in recovery and increased mortality.
Aim: This study was performed with the aim of determining the anxiety and depression of patients with corona and related factors.
Setting and Design: This study was conducted in general and special wards (coronary care unit) in Iran (Imam Khomeini and Bu Ali Sina in Sari and Razi hospitals in Ghaemshahr) in 2020.
Materials and Methods: Patients were selected by accessible sampling. The Hospital Anxiety and Depression Scale was used to assess anxiety and depression.
Statistical Analysis Used: This descriptive-analytical study was performed on 150 patients with Covid-19 admitted. Data were analyzed using SPSS software version 21, descriptive statistics and inferential statistics such as t-test, Chi-square, Fisher, Pearson correlation coefficient, and multiple linear regression test.
Results: The mean score of patients' anxiety was 6.83 ± 5.16, and the mean score of depression was 7.09 ± 4.37. According to the multiple linear regression test, depression with standard β (ß =0.53) and with standard β (ß =0.21) explore 42% of variance of anxiety. Anxiety (β =0.56), temperature (β =0.2), anorexia (β =0.18), and respiratory rate (β =0.12) explore 45% of variance of depression, respectively.
Conclusion: The results of this study indicated a high prevalence of anxiety and depression in hospitalized patients with corona disease. Therefore, further study of related factors and planning appropriate interventions according to the results of the study is recommended.

Keywords: 2019 Coronavirus disease, Corona, Hospital anxiety and depression


How to cite this article:
Alishah M, Bagheri-Nesami M, Babaei SR, Alishah M. An investigation of hospital anxiety and depression and associated factors in COVID-19 patients. J Nurs Midwifery Sci 2021;8:205-11

How to cite this URL:
Alishah M, Bagheri-Nesami M, Babaei SR, Alishah M. An investigation of hospital anxiety and depression and associated factors in COVID-19 patients. J Nurs Midwifery Sci [serial online] 2021 [cited 2021 Aug 2];8:205-11. Available from: https://www.jnmsjournal.org/text.asp?2021/8/3/205/321735




  Introduction Top


The 2019 coronavirus disease (COVID-19) is one of the severe acute respiratory infections reported for the first time on December 31, 2019 in Wuhan, the capital of Hubei Province in China. The pathogenic agent of the disease belongs to a large family of beta-coronaviruses whose transmission routes are animal reservoirs. There is a need for further research on the detection of preventive strategies and clinical manifestations.[1] The incubation period (the time elapsed between infection and appearance of the first symptoms of disease) is currently estimated to be between 2 and 11 days and can be as long as 14 days.[2] Some patients may experience fever, fatigue, dry cough, sore throat, pain and discomfort, nasal congestion, rhinorrhea, or diarrhea. These symptoms are usually mild with a gradual onset. However; some patients may also be asymptomatic. Numerous physicians from all over Iran reported the prevalence of shiver (even shaking shivering), anosmia at the onset of the disease, and extreme fatigue/bruising.[3] One in six patients with COVID-19 is seriously suffering from respiratory problems.[4] Two groups of people are at risk for COVID-19: those with underlying diseases (such as diabetes and cardiovascular disease) and those with immunodeficiency (such as chemotherapy and organ transplantation). On August 13, 2020, the World Health Organization (WHO) announced the involvement of 216 countries with coronavirus.[2] Anxiety in a COVID-19 patient can occur due to a variety of factors such as respiratory problems, go to medical centers to visit a doctor, definitive diagnosis of COVID-19, hospitalization in general ward or intensive care unit, and published statistics of deaths due to this disease by the Ministry of Health and Medical Education and WHO.[4]

Anxiety and depression are the most prevalent psychological disorders. Hence, it is clinically important to understand the parameters affecting the development of such symptoms.[5] Anxiety is a reaction in the face of ambiguous danger with internal and unknown causes and possesses an unconscious and uncontrollable origin, in which many factors are involved.[6] Anxiety is the most common psychological reaction in response to novel changes and experiences. It indicates an imminent danger that forces the individual to take the necessary measures to control or reduce the resulting complications.[7] Depression is a mood disorder manifested with symptoms such as low mood, loss of interest or pleasure, weight loss, insomnia, tiredness, emptiness, feelings of guilt, difficulty concentrating, and thoughts of death.[8] Depression can develop following infectious disease, isolation, and strict caution in hospital settings. Psychological distress, along with anxiety and depression, will have a negative impact on patients' quality of life and prognosis. Health-care providers not only should treat physical illnesses but also must pay attention to treating patients' depression and anxiety.[9] Knowing the level of anxiety and depression in COVID-19 patients will help the medical team involved in the health care and treatment of these patients for short-term and long-term planning. There are several descriptive studies on the prevalence of hospital depression and anxiety in various patients. In a study in China, Lai et al. reported that anxiety and depression level among hospital staff (physicians and nurses) providing care for COVID-19 patients is equal to 44.6 and 50.4, respectively.[10] Ramezani et al. (2020) investigated the role of anxiety and cortisol levels in the outcomes of COVID-19 patients, the results of which revealed a significant correlation (P = 0.004 and r = 0.842) between anxiety and cortisol levels.[11] Yohannes et al. reported 36% and 40% anxiety and depression levels, respectively, in chronic obstructive pulmonary disease (COPD) patients with respiratory problems.[12] Ghaleeha et al. (2009) estimated the incidence of depression and anxiety in hospitalized patients with acute coronary syndrome as 66.6% and 47.5%, respectively.[13] Since the symptoms such as anxiety, depression, fear, and sleep problems are the most prevalent problems during the COVID-19 epidemic,[14] and because there are limited studies on hospital anxiety and depression and related factors in COVID-19 patients, the present study aimed to investigate and correlation between hospital depression and anxiety and associated factors in COVID-19 patients hospitalized in Iran (Sari and Ghaemshahr) to design and implement appropriate preventive health care, medical treatment, and support measures based on the attained results.


  Materials and Methods Top


The present descriptive-analytical of correlation type study was conducted on 150 COVID-19 patients admitted to general wards and coronary care unit at referral hospitals of Imam Khomeini and Bu-Ali Sina in Sari and Razi Hospital in Ghaemshahr for 3 months during April to June 2020. The statistical population of the study included all COVID-19 patients admitted to the mentioned medical centers in the considered time interval. This research was approved by the Research Ethics Committee of Mazandaran University of Medical Sciences, Iran (IR.MAZUMS.REC.1399.7544). The sample size was calculated according to previous studies using the formula for determining sample size. Considering the mean (standard deviation), Anxiety and Depression subscales reported by Moradian et al. in a study entitled “Hospital Anxiety and Depression in Patients with Coronary Artery Disease,” 7.23 (2.6) and 6.74 (2.6), respectively,[15] the sample size of the present study was estimated at 150 patients who were selected by accessible sampling method.

N = z (1 − a/2) 2. S2/d2 = (1/96) 2× (2/6) 2/(0/42) 2 = 150.

Inclusion criteria were hospitalization due to COVID-19 symptoms, age over 18 years, no mental illness under treatment (based on patient statements or patient medical records), consciousness and ability to communicate with researcher, passage of 24 h from the onset of infection, and willingness to participate in research. Ethical considerations in this study were willingness to participate in research, free withdrawal without restriction at any time, explanation of research objectives and methodology, and confidentiality of information.

Demographic information of the patient including age, sex, marital status, level of education, occupation, economic status, number of hospitalization, head of the family, number of family members, high-risk behavior, insurance coverage, location, symptoms at the time of admission and during hospitalization, infection other family members, underlying disease, and vital signs at the time of admission. The required data were collected using demographic profile and Hospital Anxiety and Depression Scale (HADS), as well as interviewing patients and extracting their medical records. HADS, designed by Zigmond and Snaith in 1983, is a 14-item self-report tool for determining the presence and severity of anxiety and depression symptoms in patients,[16] including 7 questions on anxiety and 7 questions on depression; each question is rated on a 4-point Likert scale and scored between 0 and 3, with the maximum score of 21 points in each subscale.[17] A score of 0–7 indicates healthy status (asymptomatic), 8–10 means mild anxiety or depression, and 11–21 shows severe anxiety or depression (clinical symptoms) for both subscales.[18] Totally, out of 21 points earned, a score higher than 8 in each section is considered as the presence of anxiety and depression.[19] Kaviani has nationalized the validity and reliability of the HADS for use in the clinical population by conducting a study among depressed and anxious individuals compared with a healthy population. In the aforementioned study, the scale validity was reported with Cronbach's alpha coefficient of 0.7 and 0.85 in the depression and anxiety subscales, respectively, and its reliability was confirmed using the test–retest method in the depression (P < 0.001, r = 0.77) and in the anxiety (P < 0.001 and r = 0.81) subscales, respectively.[17] Cronbach's alpha coefficient of this instrument in the present study was 0.85 and 0.79 for the anxiety and depression subscales, respectively, and 0.87 for the whole scale.

Data were analyzed by SPSS version 21 software (SPSS 21 version, Chicago, IL, USA) using descriptive statistics (mean and standard deviation) and inferential statistics (t-test, Chi-square, Fisher, Pearson correlation coefficient, and multiple linear regression test) at a significance level of P < 0.05.


  Results Top


This study consisted of 150 participants in the age range of 18–83 years with a mean age of 49.32 ± 14.65 years, including 58.7% female and 41.3% male. The mean score of anxiety was 6.83 ± 5.16 and the mean score of depression was 7.09 ± 4.37, which are at a severe level due to the range above 11. The mean total score of anxiety and depression was 13.93 ± 8.58. The most prevalent clinical symptoms were dyspnea (53.3%), fever (46%), cough (45.4%), shiver (37.3%), myalgia (32.7%), weakness and lethargy (29.3%), nausea (22%), and headache (22%), respectively. The least common clinical symptoms included anorexia (17.3%), chest pain (11.3%), abdominal pain (11.3%), sore throat (8.7%), diarrhea (8%), vomiting (8.7%), palpitations (4%), hemoptysis (3.3%), loss of smell (3.3%), constipation (2.7%), kidney problems (1.3%), and seizure (1.3%), respectively. The highest frequency for underlying diseases was related to obesity (46.7%), diabetes (30.7%), hypertension (30.7%), cardiovascular disease (20.7%), hyperlipidemia (12.7%) immunodeficiency (8.7%), lung disease (8%), anemia (8%), cancer (8%), kidney failure (6.7%), hypothyroidism (5.3%), multiple sclerosis (2.7%), corticosteroid therapy (2%), and organ transplantation (2%), respectively.

Pearson correlation test was performed to examine the correlation between quantitative variables (including age, number of family members, duration of hospitalization, body mass index, arterial oxygen saturation, heart rate, respiration rate, and temperature) and the total score of anxiety and depression, the results of which showed a significant correlation with the total score of anxiety and depression (P = 0.0001, r = 0.91) and with the depression score (P = 0.0001, r = 0.61).

Among the qualitative variables, Chi-square test revealed a significant correlation between anxiety level and clinical symptoms of weakness and lethargy (P = 0.001, χ2 = 15.42) and history of hypertension (P = 0.004, χ2 = 13.33), history of lung disease (P = 0.043, χ2 = 17.36) and history of HLP (P = 0.008, χ2 = 11.92). There was no significant correlation between quantitative variables and anxiety level (P > 0.05). T-test statistics indicated a significant difference in the anxiety level between the two gender, males with a mean level of 4.82 ± 4.93 and females with a mean level of 8.25 ± 4.87. So that the anxiety level in women was higher than in men (P < 0.001, t = 4.22) [Figure 1].
Figure 1: Comparison of anxiety in men and women

Click here to view


In the analysis of qualitative variables with Chi-square test, there was a significant correlation between the depression level and the clinical signs of weakness and lethargy (P = 0.006, χ2 = 12.41), anorexia (P = 0.017, χ2 = 10.17), and underlying heart disease (P = 0.002, χ2 = 21.44). In the study of the correlation between quantitative variables and depression score, the depression score had a significant correlation with total anxiety and depression score (P = 0.0001, r = 0.88), respiration rate (P = 0.032, r = −0.17), and temperature (P = 0.014 and r = 0.19). There was no significant correlation between other qualitative and quantitative variables with depression score (P > 0.05). Previously, Kolmogorov–Smirnov test examined the normality of the data including anxiety and depression and found that the data had a normal distribution with P > 0.05.

Enter method of multiple linear regression was performed to investigate the correlation between anxiety and the variables of weakness and lethargy, history of hypertension, history of hyperlipidemia, history of lung disease, gender, and depression (R2 = 0.42). As seen in [Table 1], the model is fit (P < 0.001 and F = 19.44). It was indicated that depression and gender explain 42% of the variance changes in anxiety. On the other hand, among the mentioned variables, the depression with standardized regression coefficient beta of 0.53 (ß =0.53) explains a higher level of anxiety than gender (ß =0.21) and (P < 0.05). The correlation of other variables was not statistically significant [Table 2].
Table 1: Determine the appropriateness of the statistical model (anxiety)

Click here to view
Table 2: Analysis of correlation between anxiety and some variables using multiple linear regression with enter method test

Click here to view


Y = 2.65 + 0.53 depression + 0.21 gender.

Enter method of multiple linear regression was tested to evaluate the correlation between depression and the variables of temperature, respiration rate, weakness and lethargy, anorexia, history of cardiovascular disease, and total anxiety and depression score. [Table 3] shows that the model is fit (P < 0.001 and F = 19.03). [Table 2] and [Table 4] show that the model is suitable.
Table 3: Determine the appropriateness of the statistical model (depression)

Click here to view
Table 4: Analysis of correlation between depression and some variables using multiple linear regression test

Click here to view


According to R2 = 0.45 and P < 0.001, the following variables explain 45% of the variance changes in depression. On the other hand, among the above variables, anxiety (β = 0.56), temperature (β = 0.2), anorexia (β = 0.18), and respiration rate (β = 0.12), respectively, explain higher level of depression according to ß value and P < 0.05 [Table 4].

Y = 55.25 + 0.56 anxiety + 0.12 res. rate + 0.2 temp. +0.18 anorexia.


  Discussion Top


The purpose of this study was to investigate the correlation of hospital anxiety and depression with related factors in COVID-19 patients. The results of which demonstrated that the prevalence of COVID-19 causes cognitive problems such as anxiety and depression. There is ample evidence that the spread of communicable diseases and the associated quarantine can have devastating psychological effects. During the infection outbreak and its socioeconomic consequences such as the closure of businesses and educational institutions, many issues arise in the community that can lead to feelings of tension and anxiety.[20] The COVID-19 outbreak in Iran has endangered the physical and mental health of people, increased the fear of possible death due to viral infections, and led to psychological stress.[21] According to the available databases, no study has been published about hospital anxiety and depression and its associated factors in COVID-19 patients. However, hospital anxiety and depression were assessed in some other patients, which will be analyzed below. Consistent with the present study, similar results have been separately reported by Ghaleeha et al.[13] and Bairaghi et al.[22] on depression and anxiety among hospitalized cardiac patients. The same result was obtained in a study entitled “Levels of Anxiety and Depression in Hospitalized COPD patients,”[12] while inconsistent findings were reported by Farrokhnejad et al.[23] who examined hospital anxiety and depression in elderly with chronic heart failure, which can be attributed to the nature of the disease because cardiovascular disease is a chronic condition and that the patient would feel less risk of death due to getting used to the disease. However, the patients in the present study were faced with an acute illness that is still unknown and has no definitive cure and that the fear of death and lack of known treatment could be a reason for the increase in anxiety and depression level.

Regression analysis results demonstrated that depression and gender accounted for 42% of the variance changes in anxiety, and the mean anxiety level in female participants was higher than in men. This finding is consistent with studies by Zhang et al.[24] and Krammer et al.,[25] who both examined COVID-19 anxiety-related psychological disorders in hospital staff, and a study by Haug et al.[26] who evaluated anxiety and depression in the general population. No difference was reported in another study on anxiety and depression in hospitalized patients with rheumatoid arthritis.[27] This difference may be due to the fact that women are more affected during epidemics[28] and are exposed to stress due to a lack of financial and emotional support and their great responsibilities in caring for children, leading to an increased risk of mental disorders such as anxiety and depression in women compared with men.[29] In contrast, men have higher social support from those around (spouse and children), which reduces their anxiety.[30],[31],[32] On the other hand, the anxiety is a major feature of critical situations,[33] which can be exacerbated by fear of death, fear of financial issues, and unemployment as causes of anxiety.[34] The higher level of anxiety in women in the present study seems to be justifiable given the critical situation given that 43% of women were housekeepers.

In this study, the correlation between anxiety and depression was significant, meaning that increasing the severity of depression elevates the simultaneous risk of anxiety, which in turn can lead to more physical and mental problems in COVID-19 patients if left untreated, consistent with studies by Kawachi et al.,[35] Moradian et al.,[15] and Ghaleeha et al.[13] on depression and anxiety among heart patients.

In the present study, the variables such as anxiety, temperature, respiration rate, and anorexia could explain 45% of the variance changes in depression; no consistent study was found in this field. Wang et al. examined immediate psychological responses and related factors in the general population during the initial phase of the COVID-19 outbreak. In this study, the physical symptoms of myalgia, dizziness, coryza, cough, respiratory distress, and sore throat were significantly associated with high levels of anxiety and depression.[36] Özdin and Bayrak Özdin[37] also conducted a study to assess the level of depression, anxiety, and health anxiety and related effective factors in the community during the COVID-19 epidemic. According to their research, which was conducted by online HADS and HAI scales, gender (female) and history of mental illness were correlated with anxiety; and gender, underlying illness, and history of mental illness with health anxiety, as well as residence (suburbs) with depression and anxiety. The discrepancy among the studies of Wang et al. and Özdin and Bayrak Özdin with the present study may be due to differences in the study population, as these studies were performed on the general public while the present study on hospitalized patients. On the other hand, apart from the mentioned cases, different cutoff points, type of disease, sampling method, and type of evaluation tools are also important for measuring the level of anxiety and depression, which can report different results. The important point of the aforementioned studies is the correlation of clinical symptoms with the severity of anxiety and depression, which can be considered to confirm the results of the present study.


  Conclusion Top


Although there is a small number of psychological studies in Iran on the epidemiology of communicable diseases in general, and COVID-19 patients in particular, the major role of anxiety and depression and related factors in social crises can be considered and recruited to explain these results. Due to the prevalence of anxiety and depression in COVID-19 patients, appropriate prevention and screening measures should be performed in such patients. According to the results of the present study, since women are more prone to anxiety and depression, further support and education seem to be necessary in this group. In the present study, the correlation of anorexia, respiration rate, and temperature with depression suggests special attention to physical issues in addition to mental problems in educational planning to reduce depression so that reducing the physical problems can mitigate the mental health problems such as anxiety and depression in patients. Therefore, the priority in future psychiatric planning may depend on these. Investigating the effect of counseling and training by treatment staff on reducing hospital anxiety and depression in COVID-19 patients is a question that can be answered with future studies and reviews.

Limitations

Unfortunately, the clinical conditions of several patients suffering from COVID-19 admitted to the intensive care units were critical and they were unable to participate in the study.

This study was performed on patients with COVID-19 admitted to three teaching hospitals based on the cities of Sari and Ghaem Shahr, northern Iran, so the generalizability of the results to all patients affected with this pandemic should be done with caution.

Since the present study was a descriptive-correlational research, causal relationships could not be inferred.

Suggestions

Similar studies should be conducted, recruiting larger sample size as well as patients affected with other infectious diseases of the respiratory system all over Iran.

Conflicts of interest

There are no conflicts of interest.

Authors' contribution

Mrs M. Alishah and Babaei contributed with the study conception, data collection, and drafting the manuscript. M. Bagheri supervised the study design and helped with conducting this study. Alishah was the study advisor. All the authors critically evaluated the paper and provided the final draft.

Financial support and sponsorship

Nil.

Acknowledgment

The authors of this article express their gratitude for the cooperation and financial support of the Vice Chancellor for Research of Mazandaran University of Medical Sciences (IR.MAZUMS.REC.1399.7544), the hardworking nurses of referral hospitals of Imam Khomeini and Bu-Ali Sina in Sari and Razi Hospital in Ghaemshahr, and all participating patients.



 
  References Top

1.
Najafi M, Nazari M, Pouragha B, Jamal Mohammadi A, Baghian N, Ashrafi E, et al. Studying COVID-19 Disease Management: A Review Study. Evidence Based Health Policy, Management and Economics. 2021;5:63-74.  Back to cited text no. 1
    
2.
Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. Journal of medical virology. 2020;92:441-7.  Back to cited text no. 2
    
3.
Medicine and Two. Flowchart Diagnosis and Treatment of COVID 19 Disease at the Outpatient and Inpatient Service Levels. National Guidelines Corona New Virus Ministry of Health and Medical Education February. Tehran: Ministry of Health and Medical Education; 1399.  Back to cited text no. 3
    
4.
WHO. Novel Coronavirus–China. 2020. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/. [Last accessed on 2020 Feb 01].  Back to cited text no. 4
    
5.
Sadock BJ, Sadock VA, Ruiz P. Synopsis of Psychiatry: Behavioral Sciences, Clinical Psychiatry. APA Psyc Net (American Psychological Association). 5th ed (Fifth Edition): Wolters Kluwer; 2015. p. 418-36.  Back to cited text no. 5
    
6.
Aghajani M, Valiee S, Tol A. Death anxiety amongst nurses in critical care and general wards. Iran J Nurs 2010;23:59-68.  Back to cited text no. 6
    
7.
Kooshan M, Vagei C. Psyciatric Nursing-Mental Health. 2nd ed. Tehran: Andisheh Rafiee Publications; 2010.  Back to cited text no. 7
    
8.
Sousa VD, Zauszniewski JA, Musil CM, McDonald PE, Milligan SE. Testing a conceptual framework for diabetes self-care management. Res Theory Nurs Pract 2004;18:293-316.  Back to cited text no. 8
    
9.
Zhou J, Xu XP, Xu F, Shao Y, Zou MH, Yu JJ, et al. Clinical symptoms and psychological changes of patients with COVID-19 in Jiangxi Province. Research Squari 2020;1:1-27.  Back to cited text no. 9
    
10.
Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, et al. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open 2020;3:e203976.  Back to cited text no. 10
    
11.
Ramezani M, Simani L, Karimialavijeh E, Rezaei O, Hajiesmaeili M, Pakdaman H. The role of anxiety and cortisol in outcomes of patients with COVID-19. Basic Clin Neurosci 2020;11:179-84.  Back to cited text no. 11
    
12.
Yohannes AM, Baldwin RC, Connolly MJ. Mood disorders in elderly patients with chronic obstructive pulmonary disease. Rev Clin Gerontol 2000;10:193-202.  Back to cited text no. 12
    
13.
Ghaleeha A, Emami F, Naghsh Tabriz B, Hassani Reyhaneh A. Extensive study of depression and anxiety in patients with acute coronary syndrome hospitalized in the cardiac ward of Ekbatan Hospital in Hamadan. Ebn Sina Clin Med J 2009;17:43-9.  Back to cited text no. 13
    
14.
Torales J, O'Higgins M, Castaldelli-Maia JM, Ventriglio A. The outbreak of COVID-19 coronavirus and its impact on global mental health. Int J Soc Psychiatry 2020;66:317-20.  Back to cited text no. 14
    
15.
Moradian S, Ebadi A, Saeid Y, Asiabi M. Hospital anxiety and depression in patients with coronary artery disease. Iranian Journal of Psychiatric Nursing (Ijpn) 2013;1:54-61.  Back to cited text no. 15
    
16.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.  Back to cited text no. 16
    
17.
Kaviani H, Seyfourian H, Sharifi V, Ebrahimkhani N. Reliability and validity of anxiety and depression hospital scales (HADS): Iranian patients with anxiety and depression disorders. Tehran Univ Med J 2009;67:379-85.  Back to cited text no. 17
    
18.
Parsamehr M, Afshani A, Nikoo F. Relationship between anxiety and depression with quality of life after coronary artery bypass graft. IJN 2015;28:106-17.  Back to cited text no. 18
    
19.
Sadoughi M, Mehrzad V, MohammadSalehi Z. The relationship between anxiety, depression, and quality of life among breast cancer patients in Seyedoshohada hospital in Isfahan in 2016: The mediating role of resilience. J Rafsanjan Univ Med Sci 2017;16:395-408.  Back to cited text no. 19
    
20.
Maynard MS, Perlman CM, Kirkpatrick SI. Food insecurity and perceived anxiety among adolescents: an analysis of data from the 2009–2010 National Health and Nutrition Examination Survey (NHANES). J Hunger Environ Nutr 2017;14:339-51.  Back to cited text no. 20
    
21.
Deng SQ, Peng HJ. Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. J Clin Med 2020;9:575.  Back to cited text no. 21
    
22.
Bairaghi N, Tonekaboni SH, Vakili G. Anxiety and depression in hospitalized cardiac patients, the prevalence of the condition (treatment and referral). J Hormozgan Univ Med Sci 2007;9:261-4.  Back to cited text no. 22
    
23.
Farrokhnejad AP, Bastani F, Haghani H, Valipour O. Nosocomial anxiety and depression in the elderly with chronic heart failure. Iranian Journal of Nursing 2019;32:87-97.  Back to cited text no. 23
    
24.
Zhang WR, Wang K, Yin L, Zhao WF, Xue Q, Peng M, et al. Mental health and psychosocial problems of medical health workers during the COVID-19 epidemic in China. Psychother Psychosom 2020;89:242-50.  Back to cited text no. 24
    
25.
Krammer S, Augstburger R, Haeck M, Maercker A. Adjustment disorder, depression, stress symptoms, corona related anxieties and coping strategies during the corona pandemic (COVID-19) in swiss medical staff. Psychother Psychosom Med Psychol 2020;70:272-82.  Back to cited text no. 25
    
26.
Haug TT, Mykletun A, Dahl AA. The association between anxiety, depression, and somatic symptoms in a large population: The HUNT-II study. Psychosom Med 2004;66:845-51.  Back to cited text no. 26
    
27.
Covic T, Cumming SR, Pallant JF, Manolios N, Emery P, Conaghan PG, et al. Depression and anxiety in patients with rheumatoid arthritis: Prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS). BMC Psychiatry 2012;12:6.  Back to cited text no. 27
    
28.
Kim SJ, Han JA, Lee TY, Hwang TY, Kwon KS, Park KS, et al. Community-based risk communication survey: Risk prevention behaviors in communities during the H1N1 crisis, 2010. Osong Public Health Res Perspect 2014;5:9-19.  Back to cited text no. 28
    
29.
Welch JL, Austin JK. Stressors, coping and depression in haemodialysis patients. J Adv Nurs 2001;33:200-7.  Back to cited text no. 29
    
30.
Eales CJ, Becker P, Stewart AV, Noakes TD. Predictors of the successful outcome of one year survivors of coronary artery bypass surgery: Cardiovascular topic. Cardiovasc J S Afr 2005;16:29-35.  Back to cited text no. 30
    
31.
Shafiei Z, Babaee S, Nazari A. Relationship between mood state and quality of life in patients undergoing coronary artery bypass graft surgery. IJN 2013;26:57-67.  Back to cited text no. 31
    
32.
Mallik S, Spertus JA, Reid KJ, Krumholz HM, Rumsfeld JS, Weintraub WS, et al. Depressive symptoms after acute myocardial infarction: Evidence for highest rates in younger women. Arch Intern Med 2006;166:876-83.  Back to cited text no. 32
    
33.
Newall NE, Chipperfield JG, Daniels LM, Hladkyj S, Perry RP. Regret in later life: Exploring relationships between regret frequency, secondary interpretive control beliefs, and health in older individuals. Int J Aging Hum Dev 2009;68:261-88.  Back to cited text no. 33
    
34.
Shigemura J, Ursano RJ, Morganstein JC, Kurosawa M, Benedek DM. Public responses to the novel 2019 coronavirus (2019-nCoV) in Japan: Mental health consequences and target populations. Psychiatry Clin Neurosci 2020;74:281.  Back to cited text no. 34
    
35.
Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation 1994;90:2225-9.  Back to cited text no. 35
    
36.
Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health 2020;17:1729.  Back to cited text no. 36
    
37.
Özdin S, Bayrak Özdin Ş. Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: The importance of gender. Int J Soc Psychiatry 2020;66:504-11.  Back to cited text no. 37
    


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract
Introduction
Materials and Me...
Results
Discussion
Conclusion
References
Article Figures
Article Tables

 Article Access Statistics
    Viewed108    
    Printed0    
    Emailed0    
    PDF Downloaded10    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]